JP2008526698A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526698A5
JP2008526698A5 JP2007548732A JP2007548732A JP2008526698A5 JP 2008526698 A5 JP2008526698 A5 JP 2008526698A5 JP 2007548732 A JP2007548732 A JP 2007548732A JP 2007548732 A JP2007548732 A JP 2007548732A JP 2008526698 A5 JP2008526698 A5 JP 2008526698A5
Authority
JP
Japan
Prior art keywords
sup
peptide
providing
loading factor
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007548732A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526698A (ja
JP4886702B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/013853 external-priority patent/WO2006069728A1/en
Publication of JP2008526698A publication Critical patent/JP2008526698A/ja
Publication of JP2008526698A5 publication Critical patent/JP2008526698A5/ja
Application granted granted Critical
Publication of JP4886702B2 publication Critical patent/JP4886702B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007548732A 2004-12-30 2005-12-22 ペプチド中間体断片を使用するペプチドｔ−２０の合成 Expired - Fee Related JP4886702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64091104P 2004-12-30 2004-12-30
US60/640,911 2004-12-30
PCT/EP2005/013853 WO2006069728A1 (en) 2004-12-30 2005-12-22 Synthesis of peptide t-20 using peptide intermediate fragments

Publications (3)

Publication Number Publication Date
JP2008526698A JP2008526698A (ja) 2008-07-24
JP2008526698A5 true JP2008526698A5 (enExample) 2009-02-12
JP4886702B2 JP4886702B2 (ja) 2012-02-29

Family

ID=36025222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548732A Expired - Fee Related JP4886702B2 (ja) 2004-12-30 2005-12-22 ペプチド中間体断片を使用するペプチドｔ−２０の合成

Country Status (12)

Country Link
US (1) US20060276624A1 (enExample)
EP (1) EP1833843B1 (enExample)
JP (1) JP4886702B2 (enExample)
KR (1) KR101243013B1 (enExample)
CN (1) CN101133077B (enExample)
AT (1) ATE445636T1 (enExample)
CA (1) CA2592438C (enExample)
DE (1) DE602005017188D1 (enExample)
ES (1) ES2332418T3 (enExample)
IL (1) IL184080A (enExample)
MX (1) MX2007007917A (enExample)
WO (1) WO2006069728A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261475A1 (en) * 2004-02-13 2005-11-24 Harvard Medical School Solid-phase capture-release-tag methods for phosphoproteomic analyses
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments
JP5473925B2 (ja) * 2007-10-27 2014-04-16 コーデン ファーマ コロラド インコーポレイテッド 固相および溶液相の組み合わせ技法を使用するインスリン分泌性ペプチドの合成
AU2008334783A1 (en) * 2007-12-11 2009-06-18 F. Hoffmann-La Roche Ag Insulinotropic peptide synthesis using solid and solution phase combination techniques
CN110372781B (zh) * 2019-07-29 2021-11-16 深圳佳肽生物科技有限公司 恩夫韦肽的制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994002505A1 (en) * 1992-07-20 1994-02-03 Duke University Compounds which inhibit hiv replication
US6281335B1 (en) * 1993-10-08 2001-08-28 Coulter Corporation Hybridoma and anti-KC-4 humanized monoclonal antibody
US6479055B1 (en) * 1993-06-07 2002-11-12 Trimeris, Inc. Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5817758A (en) * 1995-06-07 1998-10-06 Terrapin Technologies, Inc. P-nitrobenzyl side-chain protection for solid-phase synthesis
US6281331B1 (en) * 1998-03-23 2001-08-28 Trimeris, Inc. Methods and compositions for peptide synthesis
DE69926061T2 (de) * 1998-03-23 2006-06-01 Trimeris Inc. Verfahren und zusammensetzungen zur peptidsynthese (t-20)
US6469136B1 (en) * 1999-07-07 2002-10-22 Trimeris, Inc. Methods and composition for peptide synthesis
US20040209999A1 (en) * 2002-08-16 2004-10-21 Bohling James Charles Method of manufacturing polypeptides, including T-20 and T-1249, at commercial scale, and polypeptide compositions related thereto
AU2004200485A1 (en) * 2003-02-25 2004-09-09 Rohm And Haas Company Method of manufacturing T-20 and T-1249 peptides at commercial scale, and T-20 and T-1249 compositions related thereto
CA2593866C (en) * 2004-12-30 2013-08-06 F. Hoffmann-La Roche Ag Synthesis of peptide t-1249 using peptide intermediate fragments

Similar Documents

Publication Publication Date Title
EP0885189B9 (en) Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
Hutchins et al. A strategy for urea linked diamine libraries
JP6744669B2 (ja) 水酸基を配向基とするエステルからアミドへの変換触媒
JP2005530731A5 (enExample)
EP2366403A3 (en) Polysaccharide-protein conjugate vaccines
JP2005506354A5 (enExample)
CN108779150B (zh) 地加瑞克的制备方法及其中间体
JP2008526698A5 (enExample)
JP2009527503A5 (enExample)
CN104844710B (zh) 定向固定化pega复合型树酯的制备方法及应用
JPWO2016047794A1 (ja) 疎水性ペプチドの製造法
JP2008526699A5 (enExample)
UA94594C2 (ru) СПОСОБ ПОЛУЧЕНИЯ ПОЛИМЕРНЫХ КОНЪЮГАТОВ ДОКСОРУБИЦИНА С рН-КОНТРОЛИРОВАННЫМ ВЫСВОБОЖДЕНИЕМ ЛЕКАРСТВЕННОГО ВЕЩЕСТВА
CN101219970A (zh) 一种 n－芴甲氧羰基－n－三苯甲基－d－谷氨酰胺的合成法
Limal et al. Solid-phase synthesis of N, N′-unsymmetrically substituted ureas: application to the synthesis of carbaza peptides
JP5785177B2 (ja) ポリペプチドのネイティブライゲーション法
JP2013509396A5 (enExample)
WO2025026914A1 (en) A metal complex of fmoc protected lipopeg-peptide with metal halide salts and the preparation thereof
CA2615032A1 (en) Amide forming chemical ligation
JPH04502908A (ja) アミノ酸のトリアルキルシリルエステルおよびペプチド合成におけるその使用
JP2006014637A5 (enExample)
WO1998024461A1 (en) Peptide synthesis with sulfonyl protecting groups
TW202302620A (zh) 胺基酸或肽之製造方法、保護基形成用試藥及化合物
JP2006208012A5 (enExample)
JP2009507906A5 (enExample)